March 1, 2017Annals of Internal Medicine
PCI with drug-eluting stents ≤ 12 months before surgery was linked to increased MI and cardiac death after surgery
Key result
PCI with drug-eluting stents ≤ 12 months before surgery was linked to increased myocardial infarction and cardiac death after surgery.
Why the study?
Does surgery ≤ 12 months after PCI with drug-eluting stents increase the risk of MI and cardiac death?
Population
Patients undergoing surgery after percutaneous coronary intervention with drug-eluting stents
Design
Editorial
Authors
Discussion
Loading...
Member takes
Implication
Undergoing surgery within 12 months of receiving a drug-eluting stent is associated with an increased risk of postoperative myocardial infarction and cardiac death.
Study Design
Type
Cohort
Structured PICO
Does surgery ≤ 12 months after PCI with drug-eluting stents increase the risk of MI and cardiac death?
P
Population
Patients undergoing surgery after percutaneous coronary intervention with drug-eluting stents
E
Exposure
Surgery ≤ 12 months after PCI with drug-eluting stents
O
Outcome
Myocardial infarction and cardiac death after surgeryhard clinical
Undergoing surgery within 12 months of receiving a drug-eluting stent is associated with an increased risk of postoperative myocardial infarction and cardiac death.
Cite This Study
Borges et al. (2017) conducted a cohort in Coronary drug-eluting stent implantation prior to surgery. PCI with drug-eluting stents ≤ 12 months before surgery was evaluated on Myocardial infarction and cardiac death after surgery. PCI with drug-eluting stents ≤ 12 months before surgery was linked to increased myocardial infarction and cardiac death after surgery.